Semaglutide
A Clinical Study Comparing Semaglutide Injection and Wegovy® for Weight Management in Obese Subjects
Novo Nordisk · Phase 3 · Completed · Enrollment 408
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| TQF3510 | n/r | n/r | n/r | n/r |
| Wegovy® | n/r | n/r | n/r | n/r |
Not shown
- TQF3510: endpoint not reported
- Wegovy®: endpoint not reported